CXCL12 and chronic myelogenous leukemia, BCR-ABL1 positive: These findings are partially consistent with recent observations in a transgenic chronic myeloid leukemia (CML) mouse model in which deletion of Cxcl12 in MPCs promotes expansion of LSCs (Agarwal et al., 2019).